-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Diverticulitis and relapsed diverticulitis have seriously affected the quality of life of patients, and researchers recently assessed the role of colonectomy in improving the quality of life of patients with relapsed, complex or persistent painful diverticulitis.
in this open-label, randomized clinical trial, 90 patients with relapsed, complex or persistent painful diverticulitis were involved in random laparoscopic B colonectomy or conservative therapy.
of the study was a difference in the 6-month Gastrointestinal Quality of Life Index (GIQLi) score.
participants, 28 were men with an average age of 54.11 years and 62 were women with an average age of 57.13 years.
72 patients were included in the endpoint analysis, including 37 in the surgical group and 35 in the conservative treatment group.
85 people were included in the clinical results analysis, including 41 in the surgical group and 44 in the conservative treatment group.
six months, the average GIQLi score for the surgical group was 11.96 points higher than for the conservative treatment group (11.76 vs .0.2).
4 patients (10%) in the surgical group had serious complications of Clauien-Dindo level 3 or above, while 2 patients in the conservative treatment group and 12 patients in the conservative treatment group showed signs of new outbreaks of diverticulitis within 6 months (5% vs 31%).
study concluded that B colonectomy was better than conservative treatment in improving the quality of life of patients with relapse, complexity or persistent painful diverticulitis, but 10% of patients had severe adverse events after surgery.
。